ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Danaher has agreed to buy filtration and separation media expert Pall Corp. for $13.8 billion. At the same time, Danaher plans to separate itself into two publicly traded firms. Pall has annual sales of $2.8 billion, $1.5 billion from a life sciences segment and the remainder from an industrial segment. The Pall acquisition is Danaher’s largest since it bought diagnostics and lab equipment maker Beckman Coulter for $6.8 billion in 2011. Danaher CEO Thomas P. Joyce Jr. says Pall “strengthens our life sciences position in the strategically attractive, high-growth biopharmaceutical market.” According to industry reports, Danaher outbid Thermo Fisher Scientific for Pall. The separation will create a $16.5 billion-per-year science and technology company that will retain the Danaher name and include Pall as well as Danaher’s life sciences, diagnostics, and dental segments. A to-be-named firm with $6.0 billion in sales will contain Danaher’s remaining industrial assets.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X